Dove Medical Press Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dove Medical Press Limited - overview
Established
2003
Location
London, -, UK
Primary Industry
Media
About
Dove Medical Press Limited is an open access publisher dedicated to providing high-quality, peer-reviewed medical and scientific journals across various disciplines, ensuring the free dissemination of critical research to the global community. Dove Medical Press Limited, founded in 2003, specializes in open access publishing, focusing on diverse medical and scientific journals. The company is headquartered in New Zealand and primarily serves a global audience including North America, Europe, Asia, and Australia. Specific details about the founder and any funding history are not provided.
Dove Medical Press operates as an open access publisher specializing in a diverse array of medical and scientific journals. Their primary offerings include peer-reviewed journals that cover a wide range of disciplines, such as Clinical Ophthalmology, Patient Preference and Adherence, and Cancer Management and Research. These journals provide researchers and practitioners with access to high-quality, freely available research articles aimed at addressing critical issues in various medical fields. The company's products are utilized by a broad client base that includes academic institutions, healthcare professionals, and researchers across North America, Europe, Asia, and Australia.
By making research accessible without subscription barriers, Dove Medical Press aims to enhance the dissemination of knowledge and support compliance with institutional and funding body requirements. Dove Medical Press generates revenue primarily through institutional membership plans which provide comprehensive support packages tailored for educational and research institutions. These memberships offer institutions access to a wide array of journals, enhancing their research capabilities while ensuring compliance with open access mandates. Additionally, the company may engage in partnerships with healthcare organizations and universities, facilitating bulk reprints and special publication arrangements.
The transaction structure is largely based on B2B relationships, where institutions subscribe to access the firm’s extensive catalog of journals and publications. Specific pricing plans and details regarding individual services are set to align with the needs and scale of the purchasing entity, ensuring that the offerings cater effectively to their client base.
Primary Industry
Media
Sub Industries
Literary Publishing, Media
Website
www.dovepress.com
Total Amount Raised
Subscriber access only
Dove Medical Press Limited - timeline of key events
Dove Medical Press Limited - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|
| Revenue (USD) | 11,187,000 | 11,641,000 | - | - | - |
| % Revenue Growth (YoY) | - | 4.1% | - | - | - |
| EBITDA (USD) | 5,030,000 | 5,975,000 | - | - | - |
| Operating Income (USD) | 5,019,000 | 5,969,000 | - | - | - |
| Operating Margin | 44.9% | 51.3% | - | - | - |
| % EBITDA Margin | 45.0% | 51.3% | - | - | - |
| NET Income (USD) | 4,064,000 | 5,954,000 | - | - | - |
| % Net Margin | 36.3% | 51.1% | - | - | - |
Dove Medical Press Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.